WP
PTCT icon

Woodline Partners’s PTC Therapeutics PTCT Stock Holding History

Woodline Partners’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-744,988
Closed -$50.8M – 1122
2026
Q1 		$50.8M Buy
744,988
+173,435
+30% +$12.3M 0.19% 135
2025
Q4 		$43.4M Buy
571,553
+465,948
+441% +$33.9M 0.17% 162
2025
Q3 		$6.48M Buy
+105,605
New +$5.5M 0.03% 514
2025
Q1 		– Sell
-155,883
Closed -$7.04M – 1006
2024
Q4 		$7.04M Buy
+155,883
New +$6.67M 0.05% 417
2024
Q1 		– Sell
-226,942
Closed -$6.25M – 617
2023
Q4 		$6.25M Buy
+226,942
New +$5.19M 0.07% 290
2023
Q2 		– Sell
-421,393
Closed -$20.4M – 728
2023
Q1 		$20.4M Buy
421,393
+309,192
+276% +$14.1M 0.28% 100
2022
Q4 		$4.28M Sell
112,201
-668,336
-86% -$27.8M 0.06% 342
2022
Q3 		$39.2M Buy
780,537
+535,277
+218% +$26.2M 0.55% 33
2022
Q2 		$9.82M Buy
245,260
+36,767
+18% +$1.29M 0.15% 180
2022
Q1 		$7.78M Sell
208,493
-327,451
-61% -$12.6M 0.13% 199
2021
Q4 		$21.3M Sell
535,944
-23,850
-4% -$913K 0.31% 85
2021
Q3 		$20.8M Buy
559,794
+216,343
+63% +$8.89M 0.34% 80
2021
Q2 		$14.5M Buy
343,451
+81,917
+31% +$3.51M 0.27% 99
2021
Q1 		$12.4M Buy
261,534
+141,063
+117% +$8.38M 0.27% 98
2020
Q4 		$7.35M Sell
120,471
-172,139
-59% -$10.1M 0.2% 134
2020
Q3 		$13.7M Buy
292,610
+110,900
+61% +$5.46M 0.45% 66
2020
Q2 		$9.22M Sell
181,710
-53,576
-23% -$2.63M 0.37% 77
2020
Q1 		$10.5M Sell
235,286
-81,940
-26% -$4.13M 0.75% 43
2019
Q4 		$15.2M Buy
+317,226
New +$13.5M 0.62% 54

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Woodline Partners's PTCT Position: Q2 2026 in Review

Woodline Partners sold out of PTC Therapeutics (PTCT) in Q2 2026, closing a stake of 744,988 shares — an estimated $50.8M sold.

Woodline Partners first reported a position in PTCT in Q4 2019 and held it in 19 quarters. The position peaked at $50.8M in Q1 2026. 383 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Woodline Partners reported no remaining PTC Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Woodline Partners sold 744,988 PTC Therapeutics shares in Q2 2026, an estimated $50.8M.
  • Woodline Partners first reported a position in PTC Therapeutics in Q4 2019 and held it in 19 quarters.
  • Woodline Partners's PTC Therapeutics position peaked at $50.8M in Q1 2026.
  • 383 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.